Oktopi
PrivateLast Round
Grant
Nov 1, 2025
Total Funding Raised
$1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Oktopi is an educational software company that provides a teaching management platform to help educators and students engage in continuous learning.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oktopi Comparables
Compare Oktopi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Causaly | 69% | |
| ThinkBio.Ai, Inc. | 67% | |
| SIRION Biotech | 67% | |
Oktopi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2025 | ||||
| Seed | Mar 1, 2022 |
Oktopi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Globivest | Seed |
| Bill & Melinda Gates Foundation | Grant |
| B&Y Venture Partners | Seed |
| Faith Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2025
$1M grant from the Bill & Melinda Gates Foundation.
Oktopi Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oktopi's valuation, stock price, and market status.